Polydopamine Nanoparticles as an Organic and Biodegradable Multitasking Tool for Neuroprotection and Remote Neuronal Stimulation.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
12 Aug 2020
Historique:
pubmed: 23 7 2020
medline: 17 2 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

Oxidative stress represents a common issue in most neurological diseases, causing severe impairments of neuronal cell physiological activity that ultimately lead to neuron loss of function and cellular death. In this work, lipid-coated polydopamine nanoparticles (L-PDNPs) are proposed both as antioxidant and neuroprotective agents, and as a photothermal conversion platform able to stimulate neuronal activity. L-PDNPs showed the ability to counteract reactive oxygen species (ROS) accumulation in differentiated SH-SY5Y, prevented mitochondrial ROS-induced dysfunctions and stimulated neurite outgrowth. Moreover, for the first time in the literature, the photothermal conversion capacity of L-PDNPs was used to increase the intracellular temperature of neuron-like cells through near-infrared (NIR) laser stimulation, and this phenomenon was thoroughly investigated using a fluorescent temperature-sensitive dye and modeled from a mathematical point of view. It was also demonstrated that the increment in temperature caused by the NIR stimulation of L-PDNPs was able to produce a Ca

Identifiants

pubmed: 32693584
doi: 10.1021/acsami.0c05497
pmc: PMC8009471
doi:

Substances chimiques

Antioxidants 0
Indoles 0
Neuroprotective Agents 0
Polymers 0
Reactive Oxygen Species 0
polydopamine 0
Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

35782-35798

Références

J Control Release. 2017 Oct 28;264:306-332
pubmed: 28844756
ACS Chem Neurosci. 2017 Oct 18;8(10):2325-2334
pubmed: 28737894
Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):386-395
pubmed: 27864151
Adv Healthc Mater. 2020 Feb;9(3):e1901589
pubmed: 31854132
FEBS Lett. 2018 Mar;592(5):728-742
pubmed: 29281123
Nanoscale. 2020 May 7;12(17):9833-9841
pubmed: 32342083
ACS Nano. 2018 Sep 25;12(9):8882-8892
pubmed: 30028940
Nanoscale. 2019 Feb 28;11(9):3855-3863
pubmed: 30758009
Mitochondrion. 2008 Sep;8(4):293-304
pubmed: 18602028
Angew Chem Int Ed Engl. 2017 Nov 6;56(45):14267-14271
pubmed: 28922532
J Neurochem. 2016 May;137(4):506-17
pubmed: 26875993
Nanomedicine. 2015 Oct;11(7):1725-34
pubmed: 26003299
Biomater Sci. 2020 Mar 7;8(5):1345-1363
pubmed: 31912833
Theranostics. 2017 Jul 22;7(12):2996-3006
pubmed: 28839459
ACS Biomater Sci Eng. 2019 Feb 11;5(2):670-682
pubmed: 33405830
Neurochem Int. 2012 Jan;60(2):208-12
pubmed: 22122807
Mol Cell Neurosci. 2006 Dec;33(4):345-57
pubmed: 17000118
ACS Nano. 2010 Oct 26;4(10):6267-77
pubmed: 20925390
Adv Healthc Mater. 2014 Nov;3(11):1862-8
pubmed: 24799427
ACS Nano. 2017 Mar 28;11(3):2494-2508
pubmed: 28107625
Free Radic Biol Med. 2010 Dec 1;49(11):1646-54
pubmed: 20801212
Nanomedicine. 2020 Feb;24:102088
pubmed: 31476446
Nanoscale. 2018 Apr 19;10(15):6981-6991
pubmed: 29610822
Curr Drug Targets. 2014 Apr;15(4):454-68
pubmed: 24428525
FEBS J. 2011 Apr;278(6):941-54
pubmed: 21232014
Biochem Biophys Res Commun. 2013 Jan 25;430(4):1294-300
pubmed: 23261471
Nanomedicine (Lond). 2018 Nov;13(22):2821-2833
pubmed: 30334476
ACS Nano. 2015 Jul 28;9(7):7678-89
pubmed: 26168074
Exp Neurol. 2016 Mar;277:58-67
pubmed: 26626971
Adv Sci (Weinh). 2018 May 09;5(7):1800155
pubmed: 30027047
Pharm Res. 2013 Aug;30(8):2133-45
pubmed: 23661146
Toxicol Sci. 2012 May;127(1):256-68
pubmed: 22367688
Nanoscale. 2011 Apr;3(4):1411-20
pubmed: 21369578
Chem Rev. 2014 May 14;114(9):5057-115
pubmed: 24517847
Cell Metab. 2011 Dec 7;14(6):724-38
pubmed: 22152301
Oxid Med Cell Longev. 2018 Jan 31;2018:6435861
pubmed: 29636850
Biochim Biophys Acta. 2014 Jan;1840(1):495-506
pubmed: 24135455
Nanoscale. 2019 Nov 28;11(44):21227-21248
pubmed: 31663592
Langmuir. 2008 Jul 15;24(14):7354-64
pubmed: 18553993
Biomaterials. 2011 Sep;32(27):6374-80
pubmed: 21652066
Oxid Med Cell Longev. 2017;2017:8416763
pubmed: 28819546
Nanomedicine (Lond). 2017 Feb;12(4):403-416
pubmed: 28000542
ACS Biomater Sci Eng. 2020 Jan 13;6(1):664-672
pubmed: 33463219
Sci Rep. 2014 Oct 21;4:6701
pubmed: 25330751
ACS Omega. 2020 May 14;5(21):12451-12466
pubmed: 32548430
EMBO J. 2006 Aug 23;25(16):3900-11
pubmed: 16874299
J Parkinsons Dis. 2013;3(4):461-91
pubmed: 24252804

Auteurs

Matteo Battaglini (M)

Smart Bio-Interfaces, Istituto Italiano di Tecnologia, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy.
The Biorobotics Institute, Scuola Superiore Sant'Anna, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy.

Attilio Marino (A)

Smart Bio-Interfaces, Istituto Italiano di Tecnologia, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy.

Alessio Carmignani (A)

Smart Bio-Interfaces, Istituto Italiano di Tecnologia, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy.

Christos Tapeinos (C)

Smart Bio-Interfaces, Istituto Italiano di Tecnologia, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy.

Valentina Cauda (V)

Department of Applied Science and Technology, Politecnico di Torino, Corso Duca Degli Abruzzi 24, 10129 Torino, Italy.

Andrea Ancona (A)

Department of Applied Science and Technology, Politecnico di Torino, Corso Duca Degli Abruzzi 24, 10129 Torino, Italy.

Nadia Garino (N)

Department of Applied Science and Technology, Politecnico di Torino, Corso Duca Degli Abruzzi 24, 10129 Torino, Italy.

Veronica Vighetto (V)

Department of Applied Science and Technology, Politecnico di Torino, Corso Duca Degli Abruzzi 24, 10129 Torino, Italy.

Gabriele La Rosa (G)

Nanochemistry, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.

Edoardo Sinibaldi (E)

Bioinspired Soft Robotics, Istituto Italiano di Tecnologia, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy.

Gianni Ciofani (G)

Smart Bio-Interfaces, Istituto Italiano di Tecnologia, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH